Korsana Biosciences earnings were -$6.7M for the trailing 12 months ending Jun 30, 2026, with N/A growth year over year. The latest KRSA earnings report on Jun 30, 2026 announced Q2 2026 earnings of -$1.8M, down 44.8% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, KRSA reported annual earnings of -$3.5M, with 15.4% growth.
Korsana Biosciences Earnings Reports & History FAQ
What were Korsana Biosciences's earnings last quarter?
On KRSA's earnings call on Aug 4, 2026, Korsana Biosciences (NASDAQ: KRSA) reported Q2 2026 earnings per share (EPS) of -$2.87, up 272.73% year over year. Total KRSA earnings for the quarter were -$1.76 million. In the same quarter last year, Korsana Biosciences's earnings per share (EPS) was -$0.77.
Is Korsana Biosciences profitable or losing money?
As of the last Korsana Biosciences earnings report, Korsana Biosciences is currently losing money. Korsana Biosciences's net profit (also called net income) for the twelve months ending Jun 30, 2026 was -$6.71 million, a 244.66% increase year over year.
What was KRSA's earnings growth in the past year?
As of Korsana Biosciences's earnings date in Aug 4, 2026, Korsana Biosciences's earnings has grown year over year. KRSA earnings in the past year totalled -$6.71 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.